Estimated probabilities of neoplastic HSCs surviving once various levels are reached
. | Neoplastic HSCs, n (%) . | . | . | . | . | . | . | . | . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | 1 (0.01) . | 2 (0.02) . | 3 (0.03) . | 4 (0.04) . | 5 (0.05) . | 10 (0.1) . | 20 (0.2) . | 50 (0.5) . | 100 (1) . | ||||||||
| Mouse, % | 14 | 26 | 36 | 45 | 53 | 78 | 95 | 100 | 100 | ||||||||
| Cat, % | 17 | 31 | 42 | 52 | 60 | 84 | 97 | 100 | 100 | ||||||||
. | Neoplastic HSCs, n (%) . | . | . | . | . | . | . | . | . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | 1 (0.01) . | 2 (0.02) . | 3 (0.03) . | 4 (0.04) . | 5 (0.05) . | 10 (0.1) . | 20 (0.2) . | 50 (0.5) . | 100 (1) . | ||||||||
| Mouse, % | 14 | 26 | 36 | 45 | 53 | 78 | 95 | 100 | 100 | ||||||||
| Cat, % | 17 | 31 | 42 | 52 | 60 | 84 | 97 | 100 | 100 | ||||||||